Izofra Nazal Spray. 15ml

Description

Composition
Active substance:
Per 100 ml:
Framycetin sulphate 1.25 g, corresponding to 800 000 units.
Excipients:
Per 100 ml:
-Methyl parahydroxybenzoate 0.100 g
Sodium chloride 0.756 g
Sodium citrate 0.106 g
Citric acid monohydrate, 0.040 g of
Purified Water, 100 ml.
Description:
Transparent colorless liquid.
Product form:
Nasal Spray 1.25% in opaque polyethylene vials with 15 ml of the spray tip with a polyethylene screw cap. 1 bottle together with instructions for use placed in a cardboard box.
Contraindications
Hypersensitivity to framycetin and other antibiotics of the aminoglycoside. The drug should not be used for washing the paranasal sinuses.
Pregnancy and breast-feeding.
Dosage
12.5 mg / ml
Indications
In the combined therapy in infectious and inflammatory diseases of the upper respiratory tract, incl .: – rhinitis; – rhinopharyngitis; – sinusitis (no baffles damage).
Prevention and treatment of inflammation after surgery.
Interaction with other drugs
No clinically significant drug interactions with other drugs is not revealed.
Overdose
Due to the low degree of absorption into the systemic circulation overdose unlikely.
pharmachologic effect
Pharmacological group:
The antibiotic of the aminoglycoside.
Pharmacological properties:
The antibiotic of the aminoglycoside for topical application in otorhinolaryngology.
Bactericidal effect. It is active against most Gram-positive and Gram-negative bacteria (Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae,
Haemophilus influenza), causing the development of infection in the upper respiratory tract.
Pregnancy and breast-feeding
Contraindicated during pregnancy and lactation.
Conditions of supply of pharmacies
Prescription.
side effects
Allergic reactions.
special instructions
It should be remembered that the treatment may cause resistant strains of microorganisms.
Storage conditions
Store at temperatures above 25o C.
Keep out of the reach of children.
Dosing and Administration
Adults: one injection into each nostril 4-6 times a day.
Children: one injection into each nostril 3 times a day.
Duration of treatment – no more than 7 days.
In use, the vial should be kept upright.
Information
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist